From animal experimentation, and studies using in vitro models, there was evidence in the literature to suggest that dietary fibre may influence contractility and motility of the gastrointestinal tract and long chain (LC) n-3 polyunsaturated fatty acids (PUFAs) from marine sources may influence contractility of smooth muscle cells in blood vessels. The hypothesis of this thesis was that dietary fish oil and/or fibre influence the contractility of isolated intact sections of gut smooth muscle tissue from small animal models. Methodology was established to measure in vitro contractility of intact pieces of guinea pig ileum with the serosal side isolated from the lumen. It was demonstrated that four amino acid peptides from κ-casein (casoxins) applied to the lumen overcame morphine-induced inhibition of contraction. Using this established technology, the guinea pig was used to investigate the effects of dietary fibre and fish oil supplementation on gut in vitro contractility. In separate experiments, changes in sensitivity to electrically-driven and 8-iso-prostanglandin (PG)E₂-induced contractility were demonstrated for dietary fibre and fish oil. A modified, isolated gut super-perfusion system was then established for the rat to validate these findings. It was subsequently shown that LC n-3 PUFA from dietary fish oil significantly increased maximal contraction in response to the G-protein coupled receptor modulators, acetylcholine and the eicosanoids PGE₂, PGF₂α, 8-iso-PGE₂ and U-46619 in ileum but not colon, without changes in sensitivity (EC₅₀), when n-3 PUFA as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) had been incorporated to a similar degree into the gut total phospholipid membrane pool. It was further established that the spontaneously hypertensive rat (SHR) had a depressed prostanoid (PGE₂and PGF₂α) response in the gut that could be restored by dietary fish oil supplementation (5% w/w of total diet) in the ileum but not the colon. Importantly, the muscarinic response in the colon of the SHR was increased by fish oil supplementation with DHA likely to be the active agent. Dietary fish oil dose experiments deduced differential increases in response occurred at fish oil concentrations of 1% for muscarinic and 2.5% (w/w) for prostanoid stimulators of the ileum with no difference in receptor-independent KCl-induced depolarization-driven contractility. Studies combining high amylose resistant starch (HAMS, 10% w/w) and fish oil (10% w/w) fed to young rats demonstrated a low prostanoid response that was enhanced by dietary fish oil but not resistant starch. There was however, an interactive effect of the HAMS and fish oil noted for the muscarinic-mimetic, carbachol. Generally, resistant starch increased the large bowel short chain fatty acid pool with a subsequent lower pH. Binding studies determined that while the total muscarinic receptor binding properties of an isolated ileal membrane fraction were not affected in mature rats by dietary fish oil, young rats had a different order of muscarinic receptor subtype response with a rank order potency of M₃ > M₁ > M₂ compared to mature animals of M₃ > M₂ > M₁ with fish oil altering the sensitivity of the M₁ receptor subtype in isolated carbachol-precontracted ileal tissue. In conclusion, experiments using the guinea pig and rat gut models demonstrated that dietary fish oil supplementation, and to a lesser degree fibre, increased receptor-driven contractility in normal and compromised SHR ileum and colon. Further, changes in responsiveness were demonstrated in the developing rat gut prostanoid and muscarinic receptor populations that could be altered by dietary fish oil. Preliminary evidence suggested that fish oil as DHA may alter receptor-driven gut contractility by mechanisms involving smooth muscle calcium modulation. Defining the role that dietary fibre and fish oil, and other nutrients, play in normal and diseased states of bowel health such as inflammatory bowel disease (IBD), where contractility is compromised, are among the ongoing challenges. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1316907 / Thesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Science, 2008

No description available.

From animal experimentation, and studies using in vitro models, there was evidence in the literature to suggest that dietary fibre may influence contractility and motility of the gastrointestinal tract and long chain (LC) n-3 polyunsaturated fatty acids (PUFAs) from marine sources may influence contractility of smooth muscle cells in blood vessels. The hypothesis of this thesis was that dietary fish oil and/or fibre influence the contractility of isolated intact sections of gut smooth muscle tissue from small animal models. Methodology was established to measure in vitro contractility of intact pieces of guinea pig ileum with the serosal side isolated from the lumen. It was demonstrated that four amino acid peptides from κ-casein (casoxins) applied to the lumen overcame morphine-induced inhibition of contraction. Using this established technology, the guinea pig was used to investigate the effects of dietary fibre and fish oil supplementation on gut in vitro contractility. In separate experiments, changes in sensitivity to electrically-driven and 8-iso-prostanglandin (PG)E₂-induced contractility were demonstrated for dietary fibre and fish oil. A modified, isolated gut super-perfusion system was then established for the rat to validate these findings. It was subsequently shown that LC n-3 PUFA from dietary fish oil significantly increased maximal contraction in response to the G-protein coupled receptor modulators, acetylcholine and the eicosanoids PGE₂, PGF₂α, 8-iso-PGE₂ and U-46619 in ileum but not colon, without changes in sensitivity (EC₅₀), when n-3 PUFA as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) had been incorporated to a similar degree into the gut total phospholipid membrane pool. It was further established that the spontaneously hypertensive rat (SHR) had a depressed prostanoid (PGE₂and PGF₂α) response in the gut that could be restored by dietary fish oil supplementation (5% w/w of total diet) in the ileum but not the colon. Importantly, the muscarinic response in the colon of the SHR was increased by fish oil supplementation with DHA likely to be the active agent. Dietary fish oil dose experiments deduced differential increases in response occurred at fish oil concentrations of 1% for muscarinic and 2.5% (w/w) for prostanoid stimulators of the ileum with no difference in receptor-independent KCl-induced depolarization-driven contractility. Studies combining high amylose resistant starch (HAMS, 10% w/w) and fish oil (10% w/w) fed to young rats demonstrated a low prostanoid response that was enhanced by dietary fish oil but not resistant starch. There was however, an interactive effect of the HAMS and fish oil noted for the muscarinic-mimetic, carbachol. Generally, resistant starch increased the large bowel short chain fatty acid pool with a subsequent lower pH. Binding studies determined that while the total muscarinic receptor binding properties of an isolated ileal membrane fraction were not affected in mature rats by dietary fish oil, young rats had a different order of muscarinic receptor subtype response with a rank order potency of M₃ > M₁ > M₂ compared to mature animals of M₃ > M₂ > M₁ with fish oil altering the sensitivity of the M₁ receptor subtype in isolated carbachol-precontracted ileal tissue. In conclusion, experiments using the guinea pig and rat gut models demonstrated that dietary fish oil supplementation, and to a lesser degree fibre, increased receptor-driven contractility in normal and compromised SHR ileum and colon. Further, changes in responsiveness were demonstrated in the developing rat gut prostanoid and muscarinic receptor populations that could be altered by dietary fish oil. Preliminary evidence suggested that fish oil as DHA may alter receptor-driven gut contractility by mechanisms involving smooth muscle calcium modulation. Defining the role that dietary fibre and fish oil, and other nutrients, play in normal and diseased states of bowel health such as inflammatory bowel disease (IBD), where contractility is compromised, are among the ongoing challenges. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1316907 / Thesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Science, 2008

Nucleus is the largest cellular organelle in animal cells. Due to its bulky nature and the stiffness of nuclear lamina the nucleus constitutes the substantial problem for migrating cells where nucleus has to move. The actomyosin generated forces and LINC (Linker of Nucleoskeleton and Cytoskeleton) complex, that is composed of SUN and nesprin proteins, play key role in nuclear movement. LINC complex mechanically couples nuclear lamina to the cytoskeleton and allows the forces exerted by the cytoskeleton to move the nucleus. Perinuclear actin fibers, also termed actin cap, mechanically link focal adhesions with nucleus and they may generate forces that position the nucleus in a way that is optimal for cellular movement. However, molecular mechanism of how perinuclear actin fibers and LINC complex orchestrate the nuclear movement and functional significance of this process remain poorly understood. The specific aim was to determine the mechanisms by which perinuclear actin fibers are formed and how are these mechanisms employed to facilitate cell migration. The role of LPA-RhoA signaling axis and LINC complex in the formation of perinuclear actin fibers was also examined. It was confirmed that LPA is essencial stimulus during actin cap formation. On the other hand, FAK kinase was found necessary for...

Submitted by Marlene Santos (marlene.bc.ufg@gmail.com) on 2018-08-16T17:44:08Z No. of bitstreams: 2 Dissertação - Michelle Mendanha Mendonça - 2017.pdf: 20722346 bytes, checksum: 2ee7a850badae565954ebdb18346c83d (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2018-08-17T11:31:06Z (GMT) No. of bitstreams: 2 Dissertação - Michelle Mendanha Mendonça - 2017.pdf: 20722346 bytes, checksum: 2ee7a850badae565954ebdb18346c83d (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Made available in DSpace on 2018-08-17T11:31:06Z (GMT). No. of bitstreams: 2 Dissertação - Michelle Mendanha Mendonça - 2017.pdf: 20722346 bytes, checksum: 2ee7a850badae565954ebdb18346c83d (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2017-07-25 / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq / Within the hypothalamic areas involved in the control of cardiovascular function, neurons of the paraventricular hypothalamus play a key role, either by projecting to the sympathetic premotor neurons of rostroventrolateral medulla (RVLM) or by reaching preganglionic neurons of the spinal intermediolateral column (IML). Despite describing the role of PVH in the cardiovascular control, literature lacks of data on the PVH contribution to the control of cardiac function. In this regard, the aim of the present study was to assess whether gabaergic and adrenergic synapses, known for being active at the PVH, are involved in the control of cardiac function by its neurons in normotensive anesthetized animals. Experiments were performed in adult male Wistar rats (250-350g) that were anesthetized with urethane (1.2-1.4 g/kg i.p.) and underwent catheterization of femoral to record arterial pressure and heart rate. Femoral vein was used to inject the vasoactive drugs phenylephrine (10μg/kg) the sodium nitroprussiate (10μg/kg), the blocker of cardiac pacemaker zatebradine (1mg/kg) and to supplement anesthesia. The cardiac left ventricle was catheterized to record the left ventricular pressure and its derivative. Craniotomy allowed for injections into the PVH of: muscimol (20mM – 100nL), bicuculline (0,4mM - 100nL), propranolol (10mM – 100nL), isoproterenol (100μM – 100nL), fentolamine (13mM – 100nL), phenylephrine (30nM – 100nL). The main results were: i) inhibition of PVH by injecting GABAA agonist muscimol, reduced arterial pressure and cardiac inotropy; ii) disihibition of PVH neurons by injecting bicuculline evoked positive chronotropy and inotropy; iii) Alfa adrenergic receptors control cardiac function; iv) Beta adrenergic receptors of PVH do not influence cardiac function; v) afterload seems to poorly contribute to the PVH-evoked inotropy. Jointly, our results suggest that PVH provides substantial contribution to the tonic control of cardiac function. We conclude that the PVH participates in the control of cardiac function. Changes in the activity of these neurons by gabaergic and adrenergic influences may set autonomic control of cardiac function, thus resulting in contractile and heartbeat responses. Deepen the knowledge on the mechanisms underlying the control of central areas and its influence on the cardiovascular system may feed the understanding of cardiovascular pathophysiology. / Dentre as áreas hipotalâmicas envolvidas no controle da função cardiovascular, os neurônios do hipotálamo paraventicular (PVH) desempenham um papel fundamental no controle da função cardíaca por meio de suas projeções para neurônios pré-motores simpáticos do bulbo rostroventrolateral (RVLM) pelas projeções diretas que alcançam os neurônios pré-ganglionares da coluna intermediolateral espinhal (IML). Contudo, não há dados na literatura sobre sua contribuição para o controle da função cardíaca em animais normotensos e anestesiados. Sendo assim, o objetivo do presente estudo foi avaliar se as sinapses gabaérgicas e adrenérgicas, presentes no PVH, estão envolvidas no controle da função cardíaca por esses neurônios. Os experimentos foram realizados em ratos Wistar machos (250-350g), que foram anestesiados com uretana (1,2 a 1,4 g / kg i.p.) e tiveram sua artéria femoral canulada para registrar pressão arterial e frequência cardíaca. A veia femoral foi utilizada para injeções de fármacos vasoativos fenilefrina (10μg/kg) e nitroprussitato de sódio (10μg/kg), do bloqueador do marcapasso cardíaco zatebradina (1mg/kg) e para suplementação de anestesia. O ventrículo esquerdo cardíaco foi cateterizado para medir a pressão ventricular esquerda e sua derivativa. A craniotomia foi realizada para permitir injeções no PVH de: muscimol (20mM – 100nL), bicucullina (0,4mM - 100nL), propranolol (10mM – 100nL), isoproterenol (100μM – 100nL), fentolamina (13mM – 100nL), fenilefrina (30nM – 100nL). Os principais achados deste estudo são: i) A inibição dos neurônios do PVH pela injeção do agonista GABAA muscimol reduziu a pressão arterial e o inotropismo cardíaco; ii) A desinibição dos neurônios do PVH pela injeção de bicuculina provocou respostas cronotrópicas e inotrópicas positivas; iii) Os receptores α-adrenérgicos contribuem para o cronotropismo e inotropismo cardíacos; iv) Os receptores β- adrenérgicos do PVH não influenciam o controle da função cardíaca; v) A pós-carga exerceu pouca influência nas respostas inotrópicas controladas pelo PVH. Em conjunto, os resultados sugerem que o PVH contribui de forma relevante para o controle tônico da função cardíaca em animais normotensos e anestesiados. Assim conclui-se que o PVH participa do controle da função cardíaca.

Naringin is a flavonoid glycoside (C27H32O14) found in citrus fruits and grapes, recognized for exercising antioxidant, antiatherogenic, hypoglycemic activity, among others. Contractile and electrical effects of naringin were characterized on the heart muscle of rats. The experiments were performed in the left atrium isolated rat (tub with 8 ml, Krebs-Hanseilet, 29 ± 0.1 ° C; Stimulation: 1 gf, 1 Hz, 100 V, 1.5 ms). The force data were obtained by isometric transducer (Grass FT03), amplified (Grass P11T), digitized (DATAQ DI710) and stored in a computer for analysis. The naringin (0.003 to 6 mM) was added cumulatively to the bath to determine their influence on the contractile parameters. Curves concentration-effect of naringin were obtained after atrial preincubation with 1 uM propranolol or 1 uM nifedipine or 1 uM ryanodine or still, using atria of animals with depletion of catecholamine. The effect of naringin on electrocardiograms were obtained by Langendorff technique (10 ml / min - Milan peristaltic pump; Krebs solution at 34 ± 0.1 °C aerated with carbogen), with measurement of the left intraventricular pressure (PVE) by inserting the balloon. Data were expressed as mean ± standard error of the mean and the results were evaluated by one-way analysis of variance (ANOVA) with Tukey post test or Student t test. P values ≤ 0.05 were considered significant and statistical analyzes were performed with the GraphPad Prism© version 5.0 (GraphPad Software Inc., San Diego CA, USA). Naringin (0.03-2 mM) induced a positive inotropic effect on atrium (147%; EC50 of 0.32 ± 0.01 mM, n=5) dependent on concentration. From 3 mM, naringin reduced the contractile force. At maximum positive inotropic effect of naringin there was a decrease of systole duration of 0.11 ± 0.006 sec to 0.09 ± 0.002 sec (p <0.05) and increase in the diastole duration of 0.84 ± 0.019 sec to 0.88 s ± 0.0024 sec (p <0.05). Observed increase dT/dt (+) of 6.16 ± 1.76 gf/sec to 19.74 ± 2.64 gf/sec (p <0.01) and dT/dt (-) of 6.21 ± 1.14 gf/sec to 13.52 ± 1.78 gf /sec (p <0.01). Naringin also promoted diastolic relaxation (44%). Preincubation of the atria with propranolol (Non-selective β-adrenoceptor antagonist) or nifedipine (L- type calcium channels antagonist) or ryanodine (ryanodine receptors antagonist) abolished the positive inotropic effect induced by naringin, as well as no detectable increase in contractile force in atria of animals with depletion of catecholamines. With regard to electrical parameters, naringin shortened PRi of 48.42 ± 0.81ms to 47.31 ± 0.89ms (n = 5, p <0.05) and reduced QT intervals (QTc) of 66, 75 ms ± 2.35 to 64.36 ± 2.24 ms. Conversely, the QRS complex increased (Control: 18.5 ± 1.0 ms and Naringin: 20.83 ± 1.24 ms). This flavonoid also influenced the activity of the cardiac pacemaker, increasing heart rate of 226.9 ± 1.12 bpm to 240.2 ± 3.94 bpm. No cardiac arrhythmia event was recorded during the perfusion of the heart with naringin. The PVE suffered increase of 6%. Naringin exerts positive inotropic and chronotropic effect on cardiac muscle by indirect activation of β-adrenergic receptors through endogenous catecholamines release and promotes significant electrocardiographic changes, reducing PRi, QTc and RRi, and slow down the speed of the QRS. / A naringina é um glicosídeo flavonoide (C27H32O14) encontrado em uvas e frutas cítricas, reconhecida por exercer atividades antioxidante, antiaterogênica, hipoglicemiante, dentre outras. Os efeitos contráteis e elétricos da naringina foram caracterizados sobre o músculo cardíaco de rato. Os experimentos foram realizados em átrio esquerdo isolado de rato (cuba com 8 mL, Krebs-Hanseilet, 29 ± 0,1 °C; Estimulação: 1 gf, 1 Hz; 100 V; 1,5 ms). Os dados de força foram captados por transdutor isométrico (Grass FT03), amplificados (Grass P11T), digitalizados (DATAQ DI710) e armazenados em computador para análise. A naringina (0,003 - 6 mM) foi adicionada cumulativamente ao banho para determinar sua influência sobre parâmetros contráteis. Curvas concentração-efeito da naringina foram obtidas após a pré-incubação do átrio com 1 μM de propranolol ou 1 μM nifedipina ou 1 μM de rianodina ou ainda, usando átrios de animais com depleção de catecolaminas. Os efeitos da naringina sobre o eletrocardiograma foram obtidos através da técnica de Langendorff (10 mL/min - Bomba peristáltica Milan; Solução de Krebs a 34 ± 0,1 °C aerada com carbogênio), com mensuração da pressão intraventricular esquerda (PVE) por inserção de balonete. Os dados foram expressos pela média ± erro padrão da média e os resultados foram avaliados pela análise de variância de uma via (ANOVA) com pós-teste de Tukey ou pelo teste t de Student. Valores de p ≤ 0,05 foram considerados significativos e as análises estatísticas foram realizadas com o GraphPad Prism© versão 5.0 (GraphPad Software Inc., San Diego CA, USA). A Naringina (0,03 - 2 mM) promoveu efeito inotrópico positivo em átrio (147%; CE50 de 0,32 ± 0,01 mM; n = 5) dependente de concentração. A partir de 3 mM, a naringina reduziu a força contrátil. No efeito inotrópico positivo máximo da naringina, houve redução da duração da sístole de 0,11 ± 0,006 s para 0,09 ± 0,002 s (p < 0,05) e aumento na duração da diástole de 0,84 ± 0,019 s para 0,88 ± 0,0024 s (p < 0,05). Observado aumento da dT/dt(+) de 6,16 ± 1,76 gf/s para 19,74 ± 2,64 gf/s (p < 0,01) e da dT/dt(-) de 6,21 ± 1,14 gf/s para 13,52 ± 1,78 gf/s (p < 0,01). A naringina também promoveu relaxamento diastólico (44 %). A pré-incubação dos átrios com propranolol (antagonista β-adrenérgico não-seletivo) ou nifedipina (antagonista de canais de cálcio tipo-L) ou rianodina (antagonista de receptores de rianodina) aboliu o efeito inotrópico positivo induzido pela naringina, assim como, não se evidenciou aumento de força contrátil em átrios obtidos de animais previamente reserpinizados. Quanto aos parâmetros elétricos, a naringina encurtou o PRi de 48,42 ± 0,81 ms para 47,31 ± 0,89 ms (n = 5, p < 0,05) e reduziu o intervalo QT(QTc) de 66,75 ± 2,35 ms para 64,36 ± 2,24 ms. Por outro lado, a duração do complexo QRS aumentou (Controle: 18,5 ± 1,0 ms e Naringina: 20,83 ± 1,24 ms). Este flavonoide também influenciou a atividade do marcapasso cardíaco, aumentando a frequência cardíaca 226,9 ± 1,12 bpm para 240,2 ± 3,94 bpm. Nenhum evento de arritmia cardíaca foi registrado durante a perfusão do coração com a naringina. A PVE sofreu aumento de 6%. A naringina exerce efeito cronotrópico e inotrópico positivos em coração de rato por ativação indireta de receptores β-adrenérgicos através da liberação catecolaminas endógenas e promove alterações eletrocardiográficas significativas, ao reduzir PRi, QTc e RRi, além de lentificar a velocidade do QRS.

In the heart, the existence of an electrical memory was firstly reported by Rosenbaum et al. (1982), but Rios et al. (1975) and Garcia Moreira (1977) were those that firstly described the existence of contractile memories in the amphibian myocardium. These authors developed a mathematical model for representing such phenomenon. In the present study, we aimed to characterize two kinds of contractile memories occurring in the mammalian myocardium. One of them, depresses the tissue (the depressant memory, DM) and the other one acts by stimulating it (the excitatory memory, EM). The pivotal rationale guiding this work was: when the heart is challenged by changing the environment sources like nutrients, chemicals, temperature, etc., its behavior changes in order to optimize the energy expenditure associated with its contractility. This adaptation process allows to be reached a new state of dynamic equilibrium. In order to express such behavior, the tissue creates contractile memories for adjusting the amplitude of myocardial forces. This is provided by balancing the load of DM and EM available at each myocardial beat. The expression and accumulation of these memories were studied in the guinea pig atria submitted to the experimental protocols described previously by Seed & Walker (1988), Shimizu (2000), and Conde-Garcia (not published). The expression and accumulation of myocardial memories were described by employing two static descriptors, LODMmax and LOEMmax. They stand for the maximum load of depressant memory and the maximum load of excitatory memory, respectively. Furthermore, another pair of dynamic descriptors was also used to measure the maximum rate of erasing of the depressant memory (MREDM) and the other one to measure the maximum rate of erasing of the excitatory memory (MREEM). The static descriptors represent the transference of load of both memories but the dynamic descriptors were related to the rate of erasing of such memories. Our results brought us onto the following conclusions: 1. contractile memories are a phenomenon apart from the electrical memory because rising the external potassium from 2.7 to 7.0 mM did not modify (n n = 4) LODMmax that changed from 82,09 ± 1,58 to 81,56 ± 2,01% (p > 0,05), LOEMmax from 83,36 ± 0,56 to 90,12 ± 17,92% (p > 0,05), MREDM changed from -1,36 ± 0,67 to -1,13 ± 0,42gf/s (p > 0,05), and MREED from -2,09 ± 1,65 to -1,56 ± 1,41gf/s (p > 0,05). 2. However, the expression and accumulation of DM and EM are affected by the intracellular calcium transient. The increase of extracellular calcium from 1,37 to 5,47mM (n = 3) reduced LODMmax: from 87,56 ± 2,33 to 63,83 ± 3,78% (p < 0,05); LOEMmax from 84,36 ± 0,54 to 13,91 ± 0,11% (p < 0,05); MREDM from -2,58 ± 0,71 to -1,20 ± 0,37gf/s (p < 0,05) and MREEM from -0,90 ± 0,13 to -0,34 ± 0,05 gf/s (p < 0,05). Adding 5mM cafeine to the bath solution also reduced LODMmax from 79,88 ± 3,48 to 56,68 ± 6,62% (p < 0,05); LOEMmax from 77,14 ± 1,02 to 28,54 ± 2,11% (p < 0,05); MREDM from -1,78 ± 0,50 to -0,60 ± 0,10 gf/s (p < 0,05), and MREED from -1,74 ± 0,64 to -0,33 ± 0,14 gf/s (p < 0,05); 3. In the experimental condition employed in this work, a given beat receives both depressant and excitatory information built by the last ten beats. / A capacidade de o miocárdio memorizar foi estudada inicialmente por Rosenbaum (1982), que, entre outros, relataram uma memória elétrica no coração. Todavia, Rios e cols. (1975) e Moreira (1977) foram os primeiros a descrever a existência de memória contrátil no miocárdio de anfíbio. Eles propuseram um modelo matemático para representar esse fenômeno. A nossa proposta, contudo, visou caracterizar dois tipos de memórias contráteis. Uma delas inibe o inotropismo (memória depressora, MD) e a outra, o estimula (memória excitadora, ME). A hipótese central deste trabalho propõe que, quando o coração é desafiado por um novo ambiente (nutrientes, químicos, pH etc.), ele redefine sua atividade contrátil para que possa alcançar um novo estado de equilíbrio. Para expressar tal comportamento, o miocárdio cria memórias, visando ajustar a amplitude das forças geradas. Isto se dá por meio do balanço entre a carga de MD e de ME de cada batimento. Neste trabalho, a expressão e a acumulação destas memórias foram estudadas em átrio de cobaia, utilizando-se dois descritores para cada uma delas um estático, o IKMDmax e IKMEmax, que representam o incremento máximo de carga de MD e ME, respectivamente, e outro dinâmico VmedAMD e VmedAME - que está associado à velocidade de apagamento de cada memórias. As preparações foram ensaiadas com diferentes protocolos experimentais como os descritos por Seed & Walker (1988), Shimizu, et al. (2000) e Conde-Garcia (não publicado). Os resultados mostraram que a memória contrátil difere do fenômeno relativo à memória elétrica do miocárdio, porque, elevando-se o potássio externo de 2,7 para 7,0 mM, não houve variação significativa dos descritores, pois, para n = 3, o IKMDmax passou de 82,09 ± 1,58 para 81,56 ± 2,01% (p > 0,05), o IKMEmax passou de 83,36 ± 0,56 para 90,12 ± 17,92% (p > 0,05), a VmedAMD variou de -1,36 ± 0,67 para -1,13 ± 0,42gf/s (p > 0,05) e a VmedME foi alterada de -2,09 ± 1,65 para -1,56 ± 1,41gf/s (p > 0,05). A expressão e a acumulação das memórias são fenômenos que dependem do transiente intracelular de cálcio nas células miocárdicas. A elevação do cálcio extracelular de 1,37 para 5,47mM, para n = 3, alterou o IKMDmax: de 87,56 ± 2,33 para 63,83 ± 3,78% (p < 0,05); IKMEmax: 84,36 ± 0,54 para 13,91 ± 0,11% (p < 0,05); VmedAMD: -2,58 ± 0,71 para -1,20 ± 0,37gf/s (p < 0,05) e VmedME: -0,90 ± 0,13 para -0,34 ± 0,05 gf/s (p < 0,05). A adição de 5mM de cafeína à solução controle do banho fez o IKMDmax variar de 79,88 ± 3,48 para 56,68 ± 6,62% (p < 0,05); o IKMEmax de 77,14 ± 1,02 para 28,54 ± 2,11% (p < 0,05); a VmedAMD de -1,78 ± 0,50 para -0,60 ± 0,10 gf/s (p < 0,05) e a VmedME -1,74 ± 0,64 para -0,33 ± 0,14 gf/s (p < 0,05). Nas condições experimentais deste estudo, uma dada contração recebe informações depressoras e excitadoras que foram geradas pelos últimos dez batimentos.

Les interactions cellule-cellule et cellule-matrice extracellulaire (MEC) sont cruciales pour entretenir la cohésion tissulaire. Ces deux types d'adhésions sont fonctionnellement interconnectés par un dialogue permanent qui met en jeu des voies de signalisation convergentes régulant notamment l'architecture et la contractilité du cytosquelette d'acto-myosine sous-jacent. Ce dialogue permet d'établir un équilibre de forces intracellulaires en réponse à la tension appliquée par le milieu extérieur. L'endothélium des vaisseaux sanguins est un tissu soumis à des conditions mécaniques particulières. En plus des compressions intercellulaires subies par tout épithélium, les cellules endothéliales (CEs) doivent également subir et résister aux forces hémodynamiques du flux sanguin et à la rigidité de la lame basale – deux signaux mécaniques agissant de part et d'autre de l'endothélium. Les Cerebral Cavernous Maformations (CCM) ou encore angiomes caverneux sont des lésions vasculaires hémorragiques d'origine génétique qui se développent au niveau des capillaires du système nerveux central et qui se caractérisent par des défauts dans l'environnement proche des CEs. La perte des jonctions intercellulaires et du recouvrement par les cellules murales, l'organisation aberrante de la membrane basale aussi que la stagnation du flux sanguin sont les caractéristiques des CCM. C'est pourquoi nous avons choisi cette pathologie comme modèle intéressant de mécanotransduction mettant en jeu le dialogue entre les intégrines et les cadhérines. En effet, les trois gènes indifféremment mutés dans cette pathologie codent pour des protéines, CCM1-3, qui s'associent en un complexe ternaire et qui sont reconnues comme des acteurs importants de la régulation des jonctions adhérentes. Des études moléculaires et protéomiques montrant que le complexe CCM interagit avec la protéine ICAP-1, un régulateur négatif de l'intégrine β1, nous ont conduit à formuler l'hypothèse selon laquelle ce complexe jouerait un rôle pivot dans la signalisation croisée entre ces intégrines et cadhérines. Les études effectuées pendant ma thèse ont démontré que les protéines CCM régulent l'homéostasie tensionnelle médiée par les structures d'adhérence intercellulaires et à la MEC par leur action inhibitrice sur l'intégrine β1 et en controlant une balance d'activité entre les deux isoformes de ROCK, ROCK1 et ROCK2. Nous avons montré que, suite à la perte des protéines CCMs, la suractivation de l'intégrine β1 augmente la sensibilité des CEs aux signaux mécaniques comme la rigidité de la MEC ou les forces hémodynamiques du flux sanguin. Il en résulte une suractivation de la contractilité cellulaire dépendante de ROCK1 déclenchant une boucle de rétrocontrôle mécanique conduisant à l'amplification des tensions intra- et extracellulaire et brisant ainsi l'homéostasie tensionnelle pour favoriser le phénotype malin. / Cell-cell or cell-matrix interactions have crucial roles in the maintenance of the physical cohesion of any tissue. In addition, growing body of evidence indicates that these two adhesion systems do not act independently, but rather are functionally interconnected by a permanent crosstalk. This dialog usually operates via common molecules that trigger convergent signaling as well as by actomyosin network which, by providing physical link, contributes to establishment of intracellular force counterbalancing tension applied by extracellular surrounding. Blood vessels endothelium is a particular tissue in term of mechanical conditions. Apart from intracellular compression, endothelial lining needs to resist hemodynamic forces as well as rigidity of the basal membrane - two mechanical inputs acting from opposite sides of the endothelial layer. Cerebral Cavernous Malformation (CCM) is a sporadically acquired or inherited disease of venous capillaries within neuro-vascular unit characterized by defects in all aspects of local microenvironment. Loss of intra-endothelial junctions and mural cell coverage, aberrant organization of basal lamina as well as stagnant blood flow are features of CCM lesions. Thereby, CCM became for us an interesting model to study mechanotrasduction process and in this context, the cross-talk between integrin and cadherin mediated adhesion structures. Indeed, CCM proteins are well recognized players involved in a control of VE-cadherin mediated intracellular junctions. In addition, CCM1 was found to interact with ICAP-1, a negative regulator of β1 integrin, raising the possibility that this complex most likely acts as molecular node regulating β1 integrin/ VE-cadherin convergent signaling pathways.Studies performed during this thesis have demonstrated that CCM complex coordinates cadherin- and integrin-mediated tensional homeostasis by repressing β1 integrin activation and maintaining a balance of activity between the two isoforms of RhoA-associated kinases ROCK1 and ROCK2. We have found that β1 integrin sustained over-activation upon CCM proteins loss contributes to increased ECs sensitivity to mechanical cues, such as ECM physical reorganization or hemodynamic force that in turn activates ROCK1-dependent contractility. This establishes a positive feedback mechanical loop that breaks tensional homeostasis and switches on the malignant phenotype.

Zipper-Interacting Protein Kinase (ZIPK) is a known modulator of actin-myosin contractility in vertebrate species. Interestingly, rodent and mouse ZIPK has undergone a divergence in regulation in comparison to other vertebrate orthologs including human. Whereas the human ortholog of ZIPK requires phosphorylation of residues TT299/300 for nuclear exit, rodents and mouse require interaction with another protein termed PAR-4. In this project we completed several experiments to examine zebrafish ZIPK in development and its effect on acto-myosin contractility. It was found that zebrafish ZIPK was expressed ubiquitously in maternal stages. In zygotic stages, ZIPK expression dropped dramatically and localized to the anterior portions of the embryo. Zebrafish and human ZIPK, but not rodent ZIPK were able to increase stress fiber formation and myosin light chain-2 (MLC-2) phosphorylation in vitro. Human and zebrafish ZIPK underwent nucleocytoplasmic shuttling without PAR-4 interaction, unlike rodent ZIPK, which required PAR-4 for nuclear exit. Unlike human ZIPK, zebrafish ZIPK TT299/300AA mutants were able to undergo shuttling. Similar to human ZIPK, catalytic mutations to zebrafish ZIPK abolished or dramatically reduced activity. Through these experiments we were able to show human and zebrafish ZIPK homologs function and are regulated similarly, while the rodent ZIPK was much more unique. Although the exhibited phenotypes were similar between human and zebrafish ZIPK orthologs, the mechanism of regulation is not completely conserved.

During the epithelial-to-mesenchymal transition, the intracellular cytoskeleton undergoes severe reorganization which allows epithelial cells to transition into a motile mesenchymal phenotype. Among the different cytoskeletal elements, the intermediate filaments keratin (in epithelial cells) and vimentin (in mesenchymal cells) have been demonstrated to be useful and reliable histological markers. In this study, we assess the potential invasiveness of six human breast carcinoma cell lines and two mouse fibroblasts cells lines through single cell migration assays in confinement. We find that the keratin and vimentin networks behave mechanically the same when cells crawl through narrow channels and that vimentin protein expression does not strongly correlate to single cells invasiveness. Instead, we find that what determines successful migration through confining spaces is the ability of cells to mechanically switch from a substrate-dependent stress fibers based contractility to a substrate-independent cortical contractility, which is not linked to their tumor phenotype.